WEP CLINICAL ANNOUNCES PARTNERSHIP WITH GERON CORPORATION FOR AN EXPANDED ACCESS PROTOCOL FOR IMETELSTAT
WEP Clinical (WEP) is pleased to announce a partnership [...]
WEP CLINICAL HAS PARTNERED WITH THERATECHNOLOGIES TO LAUNCH A NAMED PATIENT PROGRAM FOR EGRIFTA SV®
WEP Clinical LTD (WEP), a specialist services company that [...]
WEP CLINICAL HAS PARTNERED WITH KYOWA KIRIN TO LAUNCH CRYSViTA® (burosumab) POST-APPROVAL NAMED PATIENT PROGRAM IN ASIA PACIFIC
WEP Clinical LTD (WEP), a specialist services company that [...]
WEP CLINICAL HAS PARTNERED WITH KYOWA KIRIN TO LAUNCH POTELIGEO® (mogamulizumab) POST-APPROVAL NAMED PATIENT PROGRAM IN ASIA PACIFIC
WEP Clinical LTD (WEP), a specialist services company that [...]
WEP CLINICAL HAS PARTNERED WITH PHARMING GROUP TO SUPPLY LENIOLISIB POST-FDA APPROVAL THROUGH A POST-APPROVAL NAMED PATIENT PROGRAM
WEP Clinical LTD (WEP), a specialist services company that [...]
WEP CLINICAL PARTNERS WITH SOLASIA PHARMA K.K. TO LAUNCH DARVIAS NAMED PATIENT PROGRAM
WEP Clinical LTD (WEP), a specialist services company that [...]
WEP CLINICAL PARTNERS WITH Y-MABS THERAPEUTICS TO PROVIDE DANYELZA THROUGH A NAMED PATIENT ACCESS PROGRAM IN EUROPE
WEP Clinical (WEP) is pleased to announce a new [...]
WEP CLINICAL HAS PARTNERED WITH TAIMED BIOLOGICS TO LAUNCH A TROGARZO NAMED PATIENT PROGRAM
WEP Clinical LTD (WEP), a specialist services company that [...]
WEP CLINICAL ANNOUNCES PARTNERSHIP WITH PHARMING GROUP FOR EXPANDED ACCESS PROGRAM FOR LENIOLISIB
WEP Clinical (WEP) is pleased to announce our partnership [...]
WEP CLINICAL PARTNERS WITH SELLAS LIFE SCIENCES GROUP TO LAUNCH EXPANDED ACCESS PROGRAM FOR GALINPEPIMUT-S
WEP Clinical Inc. (WEP) is pleased to announce that [...]